Take a look at the full event guide to find out what you can learn across 3 days, including:

• Integrins 101 day to delve into the structural biology of integrins and modulation strategy
• Pliant Therapeutics, 7 Hills Pharma, and, Morphic Therapeutics’ clinical updates to overcome toxicity and safety issues
• Xintela’s superior therapeutic approach of integrin biomarker technology platform and why we believe it has $10bn commercials
• Maximize your therapeutic windows and disease indications beyond fibrosis and meet unmet medical needs in immune-oncology, autoimmune, and ophthalmology